STOCK TITAN

[Form 4] Lantheus Holdings, Inc Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Paul Blanchfield, President and Director of Lantheus Holdings, Inc. (LNTH), reported an insider sale. On 08/13/2025 he disposed of 3,060 shares of common stock at $53.57 per share, leaving him with 108,214 shares beneficially owned. The filing notes the sale was executed under a Rule 10b5-1 trading plan adopted by the reporting person on 02/27/2025. The Form 4 was signed by an attorney-in-fact on 08/15/2025.

Paul Blanchfield, presidente e membro del consiglio di amministrazione di Lantheus Holdings, Inc. (LNTH), ha comunicato una vendita da parte di un insider. Il 13/08/2025 ha ceduto 3.060 azioni ordinarie al prezzo di $53,57 per azione, rimanendo intestatario beneficiario di 108.214 azioni. La dichiarazione precisa che la vendita è stata eseguita nell'ambito di un piano di negoziazione Rule 10b5-1 adottato dalla persona che ha presentato la comunicazione il 27/02/2025. Il Modulo 4 è stato firmato da un procuratore il 15/08/2025.

Paul Blanchfield, presidente y director de Lantheus Holdings, Inc. (LNTH), informó una venta por parte de un insider. El 13/08/2025 vendió 3.060 acciones ordinarias a $53,57 por acción, quedando con 108.214 acciones de propiedad beneficiaria. La presentación indica que la venta se realizó según un plan de negociación Rule 10b5-1 adoptado por la persona informante el 27/02/2025. El Formulario 4 fue firmado por un apoderado el 15/08/2025.

Paul Blanchfield, Lantheus Holdings, Inc. (LNTH) 의 회장 겸 이사, 내부자 매도 신고. 2025-08-13에 보통주 3,060주를 주당 $53.57에 처분했으며, 처분 후 실질적으로 보유한 주식 수는 108,214주입니다. 신고서에는 해당 매도가 보고인이 2025-02-27에 채택한 룰 10b5-1 거래 계획에 따라 실행되었다고 기재되어 있습니다. Form 4는 2025-08-15에 대리인(위임장 보유자)에 의해 서명되었습니다.

Paul Blanchfield, président et administrateur de Lantheus Holdings, Inc. (LNTH), a déclaré une cession par un initié. Le 13/08/2025, il a cédé 3 060 actions ordinaires au prix de 53,57 $ par action, lui laissant 108 214 actions détenues à titre bénéficiaire. La déclaration indique que la vente a été exécutée dans le cadre d'un plan de négociation Rule 10b5-1 adopté par le déclarant le 27/02/2025. Le formulaire 4 a été signé par un mandataire le 15/08/2025.

Paul Blanchfield, Präsident und Direktor von Lantheus Holdings, Inc. (LNTH), meldete einen Insider-Verkauf. Am 13.08.2025 veräußerte er 3.060 Stammaktien zu je $53,57 und hält danach noch 108.214 wirtschaftlich begünstigte Aktien. Die Meldung weist darauf hin, dass der Verkauf im Rahmen eines Rule-10b5-1-Handelsplans erfolgte, den die meldende Person am 27.02.2025 angenommen hatte. Das Formular 4 wurde am 15.08.2025 von einem Bevollmächtigten unterschrieben.

Positive
  • Transaction executed under a Rule 10b5-1 trading plan, indicating pre-established, non-discretionary trading and stronger compliance documentation
  • Complete disclosure of post-transaction beneficial ownership (108,214 shares) allows investors to track insider holdings
Negative
  • Insider sale of 3,060 shares could be viewed as insider liquidity, though size appears limited relative to total holdings

Insights

TL;DR: Insider sale of a small portion of holdings executed under a pre-established 10b5-1 plan; not clearly material to valuation.

The reported disposal of 3,060 shares at $53.57 represents roughly 2.8% of the 111,274 shares implied prior to the sale, leaving 108,214 shares beneficially owned after the transaction. Because the sale was conducted pursuant to a Rule 10b5-1 plan adopted on 02/27/2025, this suggests the transaction followed an automated, pre-set schedule rather than a discretionary decision tied to nonpublic company developments. From an investor-impact perspective, this is typically viewed as routine insider liquidity rather than a signal of changing fundamentals. The filing provides clear numbers for outstanding insider ownership after the sale but contains no additional commentary on motivations or company events.

TL;DR: Transaction adheres to governance best practices via a documented 10b5-1 plan; disclosure is complete for the reported items.

The Form 4 identifies the reporting person as President and Director and discloses the adoption date of the 10b5-1 plan, which supports compliance and provides an affirmative defense against allegations of trading on inside information. The form includes requisite details: transaction date, price, shares sold, and post-transaction beneficial ownership. There is no indication of an amendment or additional derivative transactions. This level of specificity aligns with regulatory expectations for Section 16 reporting.

Paul Blanchfield, presidente e membro del consiglio di amministrazione di Lantheus Holdings, Inc. (LNTH), ha comunicato una vendita da parte di un insider. Il 13/08/2025 ha ceduto 3.060 azioni ordinarie al prezzo di $53,57 per azione, rimanendo intestatario beneficiario di 108.214 azioni. La dichiarazione precisa che la vendita è stata eseguita nell'ambito di un piano di negoziazione Rule 10b5-1 adottato dalla persona che ha presentato la comunicazione il 27/02/2025. Il Modulo 4 è stato firmato da un procuratore il 15/08/2025.

Paul Blanchfield, presidente y director de Lantheus Holdings, Inc. (LNTH), informó una venta por parte de un insider. El 13/08/2025 vendió 3.060 acciones ordinarias a $53,57 por acción, quedando con 108.214 acciones de propiedad beneficiaria. La presentación indica que la venta se realizó según un plan de negociación Rule 10b5-1 adoptado por la persona informante el 27/02/2025. El Formulario 4 fue firmado por un apoderado el 15/08/2025.

Paul Blanchfield, Lantheus Holdings, Inc. (LNTH) 의 회장 겸 이사, 내부자 매도 신고. 2025-08-13에 보통주 3,060주를 주당 $53.57에 처분했으며, 처분 후 실질적으로 보유한 주식 수는 108,214주입니다. 신고서에는 해당 매도가 보고인이 2025-02-27에 채택한 룰 10b5-1 거래 계획에 따라 실행되었다고 기재되어 있습니다. Form 4는 2025-08-15에 대리인(위임장 보유자)에 의해 서명되었습니다.

Paul Blanchfield, président et administrateur de Lantheus Holdings, Inc. (LNTH), a déclaré une cession par un initié. Le 13/08/2025, il a cédé 3 060 actions ordinaires au prix de 53,57 $ par action, lui laissant 108 214 actions détenues à titre bénéficiaire. La déclaration indique que la vente a été exécutée dans le cadre d'un plan de négociation Rule 10b5-1 adopté par le déclarant le 27/02/2025. Le formulaire 4 a été signé par un mandataire le 15/08/2025.

Paul Blanchfield, Präsident und Direktor von Lantheus Holdings, Inc. (LNTH), meldete einen Insider-Verkauf. Am 13.08.2025 veräußerte er 3.060 Stammaktien zu je $53,57 und hält danach noch 108.214 wirtschaftlich begünstigte Aktien. Die Meldung weist darauf hin, dass der Verkauf im Rahmen eines Rule-10b5-1-Handelsplans erfolgte, den die meldende Person am 27.02.2025 angenommen hatte. Das Formular 4 wurde am 15.08.2025 von einem Bevollmächtigten unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Blanchfield Paul

(Last) (First) (Middle)
C/O LANTHEUS HOLDINGS, INC.
201 BURLINGTON ROAD, SOUTH BUILDING

(Street)
BEDFORD MA 01730

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lantheus Holdings, Inc. [ LNTH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/13/2025 S(1) 3,060 D $53.57 108,214 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2025.
/s/ Daniel Niedzwiecki, attorney-in-fact 08/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did LNTH insider Paul Blanchfield report on Form 4?

The Form 4 reports a sale of 3,060 shares at $53.57 on 08/13/2025, leaving 108,214 shares beneficially owned.

Was the sale by the LNTH reporting person part of a 10b5-1 plan?

Yes. The filing states the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on 02/27/2025.

What is the reporting person's role at Lantheus Holdings (LNTH)?

The reporting person, Paul Blanchfield, is identified as President and a Director of Lantheus Holdings.

When was the Form 4 signed and by whom?

The Form 4 was signed by an attorney-in-fact, Daniel Niedzwiecki, on 08/15/2025.

Does the filing disclose any derivative transactions?

No. Table II for derivative securities contains no reported transactions in this filing.
Lantheus Holding

NASDAQ:LNTH

LNTH Rankings

LNTH Latest News

LNTH Latest SEC Filings

LNTH Stock Data

3.66B
66.43M
2.23%
116.39%
11.9%
Drug Manufacturers - Specialty & Generic
In Vitro & in Vivo Diagnostic Substances
Link
United States
NORTH BILLERICA